中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    REZLIDHIA (olutasidenib)
    REZLIDHIA (olutasidenib)
    departments：肿瘤科
    drug：胶囊
    Active：olutasidenib
    indication：用易感同位脱氢酶-1（IDH1）突变治疗复发或难治性急性髓细胞白血病的成年人
    Licensor：Forma Therapeutics, Inc.
    Approved Country/Region：FDA
    Approval time：2022-12-01